These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34906721)

  • 1. G-quadruplex-based CpG oligodeoxynucleotide/DOTAP complex strongly stimulates immunity in CpG motif-specific and loop-length-dependent manners.
    Tu ATT; Hoshi K; Shobo M; Yamazaki T
    Nanomedicine; 2022 Feb; 40():102508. PubMed ID: 34906721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Modified CpG Oligodeoxynucleotide Forming Guanine-Quadruplex Structure Complexes with ε-Poly-
    Zhao D; Tu ATT; Shobo M; Le NBT; Yoshikawa C; Sugai K; Hakamata Y; Yamazaki T
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of G-Quadruplex Ligands on the Topology, Stability, and Immunostimulatory Properties of G-Quadruplex-Based CpG Oligodeoxynucleotides.
    Tu ATT; Hoshi K; Ma Y; Oyama T; Suzuki S; Tsukakoshi K; Nagasawa K; Ikebukuro K; Yamazaki T
    ACS Chem Biol; 2022 Jul; 17(7):1703-1713. PubMed ID: 35765965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the Charge Ratio of Guanine-Quadruplex Structure-Based CpG Oligodeoxynucleotides and Cationic DOTAP Liposomes on Cytokine Induction Profiles.
    Le NBT; Tu ATT; Zhao D; Yoshikawa C; Kawakami K; Kaizuka Y; Yamazaki T
    Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monomeric G-Quadruplex-Based CpG Oligodeoxynucleotides as Potent Toll-Like Receptor 9 Agonists.
    Tu ATT; Hoshi K; Ikebukuro K; Hanagata N; Yamazaki T
    Biomacromolecules; 2020 Sep; 21(9):3644-3657. PubMed ID: 32857497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
    Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
    BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the Immunostimulatory Effect of Phosphodiester CpG Oligodeoxynucleotides by an Antiparallel Guanine-Quadruplex Structural Scaffold.
    Safitri FA; Tu ATT; Hoshi K; Shobo M; Zhao D; Witarto AB; Sumarsono SH; Giri-Rachman EA; Tsukakoshi K; Ikebukuro K; Yamazaki T
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The arthritogenic and immunostimulatory properties of phosphorothioate oligodeoxynucleotides rely on synergy between the activities of the nuclease-resistant backbone and CpG motifs.
    Bjersing JL; Eriksson K; Tarkowski A; Collins LV
    Inflammation; 2004 Feb; 28(1):39-51. PubMed ID: 15072229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-Quadruplex Structure Improves the Immunostimulatory Effects of CpG Oligonucleotides.
    Hoshi K; Yamazaki T; Sugiyama Y; Tsukakoshi K; Tsugawa W; Sode K; Ikebukuro K
    Nucleic Acid Ther; 2019 Aug; 29(4):224-229. PubMed ID: 30835633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides.
    Yu C; An M; Li M; Liu H
    Mol Pharm; 2017 Aug; 14(8):2815-2823. PubMed ID: 28686452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system.
    Hanagata N
    Int J Nanomedicine; 2012; 7():2181-95. PubMed ID: 22619554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of Monomeric and Dimeric G-Quadruplex-Structured CpG Oligodeoxynucleotides for Enhanced Uptake and Activation in TLR9-Positive Macrophages.
    Liao W; Tan M; Kusamori K; Takakura Y; Nishikawa M
    Nucleic Acid Ther; 2020 Oct; 30(5):299-311. PubMed ID: 32559406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endosomal translocation of CpG-oligodeoxynucleotides inhibits DNA-PKcs-dependent IL-10 production in macrophages.
    Yotsumoto S; Saegusa K; Aramaki Y
    J Immunol; 2008 Jan; 180(2):809-16. PubMed ID: 18178819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
    Lai CY; Yu GY; Luo Y; Xiang R; Chuang TH
    Front Immunol; 2019; 10():179. PubMed ID: 30800129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists.
    Meng W; Yamazaki T; Nishida Y; Hanagata N
    BMC Biotechnol; 2011 Sep; 11():88. PubMed ID: 21943407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG ODN mimicking CpG rich region of myxosporean Myxobolus supamattayai stimulates innate immunity in Asian sea bass (Lates calcarifer) and defense against Streptococcus iniae.
    U-Taynapun K; Chirapongsatonkul N; Itami T; Tantikitti C
    Fish Shellfish Immunol; 2016 Nov; 58():116-124. PubMed ID: 27629917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuning CpG motif position in nanostructured DNA for efficient immune stimulation.
    Tan M; Makiguchi N; Kusamori K; Itakura S; Takahashi Y; Takakura Y; Nishikawa M
    Biotechnol J; 2024 Apr; 19(4):e2300308. PubMed ID: 38651249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytosine-phosphate-guanine oligodeoxynucleotides containing GACGTT motifs enhance the immune responses elicited by keyhole limpet hemocyanin antigen in dairy cattle.
    Chu CY; Lee SC; Liu SS; Lin YM; Shen PC; Yu C; Lee KH; Zhao X; Lee JW
    Nucleic Acid Ther; 2011 Oct; 21(5):323-32. PubMed ID: 21916610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized Cationic Lipid-assisted Nanoparticle for Delivering CpG Oligodeoxynucleotides to Treat Hepatitis B Virus Infection.
    Chen YF; Wang Y; Wang Y; Luo YL; Lu ZD; Du XJ; Xu CF; Wang J
    Pharm Res; 2023 Jan; 40(1):145-156. PubMed ID: 36002611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides.
    Takahashi H; Misato K; Aoshi T; Yamamoto Y; Kubota Y; Wu X; Kuroda E; Ishii KJ; Yamamoto H; Yoshioka Y
    Front Immunol; 2018; 9():783. PubMed ID: 29720976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.